USA
-
Dren Bio raises US$350M to advance dibotatug towards late-stage clinical development
The clinical-stage biotechnology company will also use the proceeds to expand its research pipeline across autoimmune diseases, immunology, neurological disorders and oncology.
-
Bracco invests US$230M to build first US Contrast Media manufacturing plant in North Carolina
The new sterile manufacturing plant will complement Bracco’s existing production operations in Europe, Asia and Canada, expanding its global manufacturing network.
-
Glenmark Pharmaceuticals opens US Distribution Centre in Allentown
The facility operates in accordance with requirements established by the US Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA).
-
Setara Biosciences raises US$90M to advance rare disease drug pipeline in US
The financing attracted existing investors Deerfield Management, Canaan, Droia Ventures, EcoR1, Euclidean Capital and Regeneron Ventures.
-
Enthorin Therapeutics licenses experimental Fragile X drug candidate to Rumi Therapeutics
Enthorin will receive an upfront payment and an option exercise fee, alongside milestone payments tied to development, regulatory and commercial progress.
-
Formation Bio launches US$600M fund to expand clinical-stage drug development portfolio
Formation Bio will serve as the fund’s general partner through a wholly owned subsidiary and has committed its own capital alongside external limited partners.
-
RadNet to acquire ONRAD for US$355M to expand US hospital radiology services
RadNet could also pay an additional earnout of up to US$210 million if ONRAD achieves specified earnings before interest, taxes, depreciation and amortisation (EBITDA) targets for 2027.
-
Senseonics begins first human study of Freedom Transmitter-Free CGM System
Freedom builds on the sensing technology used in Senseonics’ Eversense 365 CGM system.
-
Regeneron extends US Ebola drug supply contract by US$270M through 2031
The agreement extends the biotechnology company’s partnership with the Biomedical Advanced Research and Development Authority (BARDA), established in 2020.
-
RunStar launches tube-free wireless blood pressure monitor in USA
The device combines an adjustable upper-arm cuff and monitoring unit in a single assembly, eliminating external tubes and cables.